Christophe Moreno

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

I. Colle, W. Laleman, P. Deltenre, 2017, Clinics and research in hepatology and gastroenterology.

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.

D. Thabut, D. Samuel, A. Duhamel, 2022, The lancet. Gastroenterology & hepatology.

Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding

A. Schoepfer, P. Deltenre, Christophe Moreno, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.

M. Ziol, V. de Lédinghen, S. Mueller, 2018, The lancet. Gastroenterology & hepatology.

Rapid Viral Response of Once-Daily Tmc435 plus Pegylated Interferon/Ribavirin in Hepatitis C Genotype-1 Patients: A Randomized Trial

M. Manns, T. Berg, P. Marcellin, 2011, Antiviral therapy.

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

R. Bataller, F. Zoulim, J. Dufour, 2019, Gut.

Liver transplant for alcoholic hepatitis: a current clinical overview

P. Deltenre, Christophe Moreno, A. Marot, 2020, Expert review of gastroenterology & hepatology.

Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202).

M. Cummings, Christophe Moreno, M. Peeters, 2013, Journal of hepatology.

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.

P. Deltenre, M. Lemoine, Christophe Moreno, 2011, Journal of hepatology.

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver

D. Franchimont, J. Devière, T. Gustot, 2006, Hepatology.

Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy.

V. Donckier, T. Gustot, Christophe Moreno, 2014, Journal of hepatology.

Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis

C. Sempoux, P. Deltenre, Christophe Moreno, 2020, United European gastroenterology journal.

N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

A. Geerts, I. Colle, B. Blomme, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Sepsis in alcohol-related liver disease.

R. Moreau, R. Jalan, G. Szabo, 2017, Journal of hepatology.

Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis

B. Colsch, C. Junot, F. Nevens, 2019, Hepatology.

Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis

R. Bataller, S. Truant, F. Pruvot, 2015, Gut.

PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis

D. Franchimont, P. Nahon, N. Ganne-Carrié, 2012, Hepatology.

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis.

M. Pavesi, V. Arroyo, P. Deltenre, 2018, Journal of hepatology.

JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1

M. Buti, M. Biermer, O. Ackaert, 2019, Hepatology.

IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

I. Colle, V. Dideberg, W. Laleman, 2011, Acta gastro-enterologica Belgica.

Perturbations in mitochondrial dynamics are closely involved in the progression of Alcoholic Liver Disease.

R. Bataller, Roger Williams, N. Heaton, 2020, Alcoholism, clinical and experimental research.

Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice.

M. Parmentier, J. Devière, T. Gustot, 2006, American journal of physiology. Gastrointestinal and liver physiology.

Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome.

G. Costamagna, J. Devière, A. Iaconelli, 2011, Gastrointestinal endoscopy.

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

B. Colsch, C. Junot, F. Nevens, 2019, Journal of hepatology.

CCR5 deficiency exacerbates T‐cell–mediated hepatitis in mice

M. Parmentier, J. Devière, T. Gustot, 2005, Hepatology.

Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta‐analysis

P. Deltenre, Christophe Moreno, E. Trépo, 2022, United European gastroenterology journal.

Alcoholic hepatitis: Towards an era of personalised management

Christophe Moreno, A. Louvet, D. Degré, 2020, United European gastroenterology journal.

Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32

R. Stauber, P. Deltenre, C. Lackner, 2020 .

Gene signature‐MELD score and alcohol relapse determine long‐term prognosis of patients with severe alcoholic hepatitis

Y. Hoshida, L. Spahr, N. Goossens, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management

I. Colle, W. Laleman, P. Deltenre, 2013, European journal of gastroenterology & hepatology.

Biliary cast syndrome after liver transplantation: A cholangiographic evolution study

N. Boon, J. Devière, M. Delhaye, 2020, Journal of gastroenterology and hepatology.

Infections in severe alcoholic hepatitis

T. Gustot, Christophe Moreno, E. Karakike, 2016, Annals of gastroenterology.

Effect of abstinence on the prognosis of patients with alcoholic liver disease: A word of caution.

J. Knebel, P. Deltenre, Christophe Moreno, 2017, Journal of hepatology.

Clinical impact of the videocapsule.

A. Van Gossum, Christophe Moreno, 2004, Gastroenterology.

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

V. de Lédinghen, D. Samuel, J. Dumortier, 2015, PloS one.

The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.

J. Devière, A. McKenzie, M. Delhaye, 2012, The American journal of pathology.

Viral clade is associated with severity of symptomatic genotype 3 Hepatitis E virus infections in Belgium, 2010-2018.

N. Hens, A. Geerts, C. Van Steenkiste, 2022, Journal of hepatology.

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Gianluca Bontempi, D. Franchimont, H. Nischalke, 2014, Hepatology.

P. Nahon, P. Deltenre, Christophe Moreno, 2014 .

Reply: To PMID 24114809.

L. N. Valenti, P. Nahon, P. Deltenre, 2014, Hepatology.

P. Nahon, P. Deltenre, Christophe Moreno, 2014 .

Reply to: “Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C”

J. Hampe, Christophe Moreno, F. Stickel, 2011 .

"Dual aetiology fatty liver disease": a recently proposed term associated with potential pitfalls.

N. Sheron, C. Lackner, Christophe Moreno, 2020, Journal of hepatology.

Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

P. Deltenre, Christophe Moreno, E. Trépo, 2021, Journal of Hepatology.

Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.

P. Vereerstraeten, M. Cnop, J. Devière, 2011, Acta gastro-enterologica Belgica.

Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-γ-secreting CD8+ T Cells

I. Colle, H. Van Vlierberghe, N. Boon, 2009, Transplantation.

Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition.

A. Van Gossum, B. Messing, P. Demetter, 2015, JPEN. Journal of parenteral and enteral nutrition.

Belgian experience with direct acting antivirals in people who inject drugs.

C. Van Steenkiste, H. Van Vlierberghe, F. Nevens, 2017, Drug and alcohol dependence.

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

H. Van Vlierberghe, F. Nevens, J. Schattenberg, 2017, BMC Gastroenterology.

Invasive aspergillosis in patients with severe alcoholic hepatitis.

J. Vincent, V. Donckier, F. Taccone, 2014, Journal of hepatology.

Perturbation of mitochondrial dynamics in Alcoholic Liver Disease.

Roger Williams, P. Sancho-Bru, J. Altamirano, 2016 .

Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial.

I. Colle, J. Devière, Christophe Moreno, 2009, Journal of hepatology.

R. Bataller, V. Shah, G. Arteel, 2019, Journal of hepatology.

The protease inhibitor, GS‐9256, and non‐nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

M. Manns, P. Marcellin, H. Mo, 2012, Hepatology.

Reply to: "Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis".

T. Gustot, Christophe Moreno, T. Sersté, 2018, Journal of hepatology.

External validation of the nomogram for individualized prediction of hepatocellular carcinoma occurrence in patients with hepatitis C virus–related compensated cirrhosis

J. Knebel, P. Deltenre, Christophe Moreno, 2017, Hepatology.

Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study

J. Vincent, J. Rello, F. Taccone, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials

M. Rudler, D. Thabut, A. Denys, 2015, European journal of gastroenterology & hepatology.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Gamal Esmat, Rui Tato Marinho, Mel Krajden, 2017, The lancet. Gastroenterology & hepatology.

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.

T. Asselah, A. Mangia, Ching-lung Lai, 2015, The New England journal of medicine.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

M. Manns, V. de Lédinghen, M. Buti, 2017, The lancet. Gastroenterology & hepatology.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

S. Alavian, R. Malekzadeh, V. Wong, 2018, The lancet. Gastroenterology & hepatology.

Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification

P. Simmonds, T. Asselah, H. Mo, 2019, Open forum infectious diseases.

Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse

H. Drexhage, M. Versnel, Christophe Moreno, 2008, Journal of leukocyte biology.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

The interleukin‐17 pathway is involved in human alcoholic liver disease

J. Devière, T. Gustot, E. Quertinmont, 2009, Hepatology.

Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients

V. E. Zagaynov, I. Popescu, J. Decruyenaere, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

M. Manns, T. Berg, G. Dusheiko, 2009 .

Hepatitis C and menopause interplay of age, gender, HCV replication and activity in progression and consequence for therapy

C. Trépo, P. Pradat, F. Bailly, 2009 .

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

J. Dumortier, R. Anty, C. Duvoux, 2015 .

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion

H. Van Vlierberghe, F. Nevens, H. Janssen, 2019, Viruses.

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

M. Manns, F. Baldanti, F. Ceccherini‐Silberstein, 2020, Journal of hepatology.

Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

T. Berg, S. Yerly, O. Kalinina, 2020, Journal of viral hepatitis.

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

M. Buti, T. Asselah, C. Sarrazin, 2016, PloS one.

Ethnic epidemiological profiles and antiviral therapy among patients infected with hepatitis C virus genotype 4: a multicenter study from Belgium.

Christophe Moreno, P. Michielsen, R. Scheen, 2015, Acta gastro-enterologica Belgica.

Predicted effects of treatment for HCV infection vary among European countries.

M. Buti, U. Siebert, N. Mühlberger, 2012, Gastroenterology.

Resource use and cost of hepatitis C-related care

I. Colle, F. Nevens, Christophe Moreno, 2012, European journal of gastroenterology & hepatology.

Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.

P. Deltenre, M. Corouge, S. Dharancy, 2011, Journal of hepatology.

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.

J. Sninsky, H. Wedemeyer, A. Potthoff, 2009, Journal of hepatology.

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

Jisoo A. Kwon, V. Wong, F. Tacke, 2022, The lancet. Gastroenterology & hepatology.

Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis.

Jishnu Das, T. Gustot, Christophe Moreno, 2020, Journal of hepatology.

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.

I. Colle, H. Van Vlierberghe, J. Knebel, 2016, Journal of hepatology.

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

I. Colle, W. Laleman, P. Deltenre, 2012, Acta gastro-enterologica Belgica.

Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.

Gianluca Bontempi, D. Franchimont, C. Sempoux, 2017, Gastroenterology.

N-Butyl-2-Cyanoacrylate in Gastric Varices: A Cause for Recurrent Sepsis

D. Valla, P. Bedossa, Christophe Moreno, 2013, The American Journal of Gastroenterology.

Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis

P. Deltenre, Christophe Moreno, E. Trépo, 2018, PloS one.

Early liver transplantation for severe alcoholic hepatitis.

F. Pruvot, D. Samuel, A. Duhamel, 2011, The New England journal of medicine.

12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation

J. Dumortier, C. Cagnot, A. Tran, 2018, Hepatology.

Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir

E. Svarovskaia, K. Chodavarapu, Christophe Moreno, 2016, Hepatology.

Treatment of a patient with genotype 7 HCV infection with sofosbuvir and velpatasvir

E. Svarovskaia, K. Chodavarapu, Christophe Moreno, 2016 .

Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.

T. Berg, H. Van Vlierberghe, S. Zeuzem, 2012, Journal of hepatology.

Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium

A. Geerts, C. Van Steenkiste, W. Laleman, 2015, PloS one.

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.

H. Cortez‐Pinto, L. Spahr, M. Thursz, 2018, Journal of hepatology.

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

K. Huse, S. Cichon, M. Rietschel, 2015, Nature Genetics.

Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

M. Manns, D. Franchimont, J. Sninsky, 2011, Hepatology.

124 IMPACT OF PNPLA3 (RS738409 C>G) POLYMORPHISM ON FIBROSIS PROGRESSION AND STEATOSIS IN CHRONIC HEPATITIS C

M. Manns, D. Franchimont, J. Devière, 2011 .

A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY CONFIRMS PNPLA 3 AND IDENTIFIES TM 6 SF 2 AND MBOAT 7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS

K. Huse, S. Cichon, M. Rietschel, 2017 .

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2021, The Lancet. Oncology.

Clinical Practice Guidelines : Management of alcohol-related liver disease q European Association for the Study of the Liver

H. Cortez‐Pinto, L. Spahr, C. Lackner, 2018 .

Guidelines EASL Clinical Practice Guidelines : Management of alcohol-related liver disease q European Association for the Study of the Liver ⇑

H. Cortez‐Pinto, L. Spahr, C. Lackner, 2018 .

Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?

D. Franchimont, Christophe Moreno, E. Trépo, 2011, Personalized medicine.

Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control.

D. Philpott, S. Girardin, P. Sansonetti, 2010, Gastroenterology.

Control of acute, chronic, and constitutive hyperammonemia by wild‐type and genetically engineered Lactobacillus plantarum in rodents

Pascal Hols, Philippe Goffin, Eric Quertinmont, 2008, Hepatology.

Expansion of Memory-Type CD8+ T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and Rapamycin

I. Colle, H. Van Vlierberghe, N. Boon, 2013, Transplantation.

Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease

A. Mangia, A. Gaggar, L. Biancone, 2021, The American journal of gastroenterology.

Plasma-signature-MELD score to predict survival in severe alcoholic hepatitis.

Quanzhen Li, Y. Hoshida, T. Gustot, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Improving the prognostic value of histopathological grading and clinical staging in renal cell carcinomas by means of computer‐assisted microscopy

C Decaestecker, I Salmon, J L Pasteels, 1999, The Journal of pathology.

Correction of all‐trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study

J. Devière, T. Gustot, E. Quertinmont, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.

D. Franchimont, Y. Momozawa, J. Devière, 2013, Journal of hepatology.

Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

OC-17 HCV burden in Europe: Impact of national treatment practices on future HCV-related morbidity and mortality through a modeling approach

M. Buti, U. Siebert, N. Mühlberger, 2011 .

Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis.

J. Pawlotsky, P. Deltenre, Christophe Moreno, 2010, Journal of hepatology.

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

N. Lanthier, P. Bedossa, A. Sanyal, 2021, The New England journal of medicine.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation

R. Moreau, D. Valla, F. Durand, 2010, European journal of gastroenterology & hepatology.

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

T. Asselah, D. Ouzan, J. Dufour, 2013 .

Normal hepatic parenchyma visibility and ADC quantification on diffusion-weighted MRI at 3 T: influence of age, gender, and iron content

T. Metens, C. Matos, Christophe Moreno, 2014, European Radiology.

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.

V. de Lédinghen, S. Chevret, S. Pol, 2018, Journal of hepatology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.

J. Whitfield, M. Pirmohamed, A. McQuillin, 2021, Journal of hepatology.

A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2019, Hepatology.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2018, International journal of cancer.

Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program.

H. Wedemeyer, A. Streinu-Cercel, Christophe Moreno, 2014, Journal of hepatology.

Laparoscopic Gastric Bypass as a Revision Procedure After Transoral Gastroplasty

J. Devière, Christophe Moreno, P. Loi, 2011, Obesity surgery.

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

I. Colle, W. Laleman, P. Deltenre, 2016, Gastroenterology.

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

D. Thabut, A. Duhamel, J. Salleron, 2013, JAMA.

Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease

R. Stauber, S. Carvalhana, H. Cortez‐Pinto, 2023, JHEP Reports.

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.

S. Chevret, S. Pol, V. Bourcier, 2022, Journal of hepatology.

Noninvasive diagnosis in alcohol‐related liver disease

Christophe Moreno, A. Hadefi, D. Degré, 2020, Health science reports.

GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

Michael I. Miller, R. Andrade, F. Nevens, 2019, Journal of Hepatology.

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients

C. Sempoux, X. Chapaux, I. Borbath, 2010, European journal of gastroenterology & hepatology.

Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin

L. Ameye, M. Bruyneel, B. Dachy, 2017, European journal of gastroenterology & hepatology.

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Dao Sen Wang, M. Poljak, F. Ceccherini‐Silberstein, 2022, JHEP reports : innovation in hepatology.

Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naïve Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial: 487

T. Asselah, J. Dufour, S. Zeuzem, 2013 .

Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol‐Associated Liver Disease

F. Jacobs, T. Gustot, Christophe Moreno, 2021, Hepatology.

The use of beta‐blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis

P. Deltenre, T. Gustot, Christophe Moreno, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.

D. Franchimont, L. Amininejad, J. Devière, 2011, Journal of hepatology.

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection

F. Zoulim, A. Horban, P. Buggisch, 2018, Virology Journal.

Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.

A. Berghold, P. Schirmacher, V. Paradis, 2021, Journal of hepatology.

Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials

A. Singal, P. Deltenre, Christophe Moreno, 2020, JHEP reports : innovation in hepatology.

Lack of the Chemokine Receptor Ccr5 Exacerbates Acute Pancreatitis in Mice

J. Devière, T. Gustot, E. Quertinmont, 2006 .

Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.

D. J. Kim, A. Duhamel, P. Nahon, 2015, Gastroenterology.

Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.

T. Berg, J. Dufour, D. Semela, 2017, Journal of hepatology.

Systematic review with meta‐analysis: automated low‐flow ascites pump therapy for refractory ascites

P. Deltenre, Christophe Moreno, D. Degré, 2019, Alimentary pharmacology & therapeutics.

The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

P. Deltenre, Christophe Moreno, F. Schepis, 2022, Hepatology.

Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.

P. Deltenre, Christophe Moreno, E. Trépo, 2018, Journal of Hepatology.

Long-term outcome of decompensated alcohol-related liver disease with steatohepatitis and Maddrey's discriminant function <32.

R. Stauber, P. Deltenre, C. Lackner, 2020, Journal of hepatology.

Long-term results of the first study of early liver transplantation for alcoholic hepatitis

D. Samuel, J. Dumortier, F. Durand, 2020, Journal of Hepatology.

Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

M. Ziol, C. Sempoux, J. Woosley, 2022, Gut.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Early liver transplantation for severe alcoholic hepatitis not responding to medical treatment: results of the French-Belgian prospective study QuickTrans

D. Thabut, D. Samuel, A. Duhamel, 2020 .

Liver transplantation in the context of organ shortage: toward extension and restriction of indications considering recent clinical data and ethical framework

V. Donckier, T. Gustot, Christophe Moreno, 2015, Current opinion in critical care.

KEY POINTS ACLF is a newly defined syndrome characterized by the presence of organ failures and high short-term mortality rate in patients with acute decompensation of cirrhosis that may benefit from liver transplantation

V. Donckier, T. Gustot, Christophe Moreno, 2015 .

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C

I. Colle, H. Van Vlierberghe, D. Deforce, 2011, European journal of gastroenterology & hepatology.

Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

J. Dumortier, F. Durand, A. Tran, 2016 .

29 EARLY TRANSPLANTATION IMPROVES SURVIVAL OF NON-RESPONDERS TO CORTICOSTEROIDS IN SEVERE ALCOHOLIC HEPATITIS: A CHALLENGE TO THE 6 MONTH RULE OF ABSTINENCE

F. Pruvot, D. Samuel, J. Dumortier, 2010 .

Fibroscan (Transient Elastography) is the most reliable non-invasive method for the assessment of severe fibrosis and cirrhosis in alcoholic liver disease

T. Gustot, P. Demetter, Christophe Moreno, 2012 .

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence

D. Nelson, J. Dillon, A. Luetkemeyer, 2021, The American journal of gastroenterology.

High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis

R. Marinho, J. Dufour, P. Thuluvath, 2017 .

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

T. Asselah, D. Ouzan, T. Hassanein, 2016, Annals of hepatology.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.

Leroy, D. Samuel, J. Dumortier, 2016 .

Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion

H. Van Vlierberghe, F. Nevens, H. Janssen, 2019, Journal of viral hepatitis.

Historical epidemiology of hepatitis C virus (HCV) in selected countries

M. Buti, R. Marinho, T. Berg, 2014, Journal of viral hepatitis.

The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C

H. Wedemeyer, A. Potthoff, C. Trépo, 2010, Hepatology.

Prescription and efficacy of daclatasvir and sofosbuvir ± ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: The CMPASS-EU cohort study

S. Bourgeois, Christophe Moreno, K. Erpecum, 2020, Cogent Medicine.

Efficacy and Safety of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir without Ribavirin in Patients with HCV Genotype 1b with or without Compensated Cirrhosis: Pooled Analysis across 5 Clinical Trials

R. Marinho, J. Dufour, A. Streinu-Cercel, 2016 .

Impact of intensive enteral nutrition in association with corticosteroïds in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial

I. Colle, W. Laleman, P. Deltenre, 2014 .

Self‐expanding metal stent should be considered in patients with cirrhosis and uncontrolled variceal bleeding

P. Deltenre, Christophe Moreno, C. Doerig, 2016, Hepatology.

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE

D. Samuel, J. Dumortier, F. Durand, 2013 .

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

M. Colombo, H. Wedemeyer, A. Streinu-Cercel, 2013, Gut.

Insulin resistance is associated with esophageal varices in alcoholic liver disease patients

N. Boon, J. Devière, P. Deltenre, 2016, European journal of gastroenterology & hepatology.

Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates

O. Moine, J. Devière, T. Gustot, 2012, Clinical and experimental immunology.

Systematic review with meta‐analysis: self‐expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding

D. Moradpour, P. Deltenre, Christophe Moreno, 2015, Alimentary pharmacology & therapeutics.

Reply to: "Alcohol-related liver disease results in significant long-term mortality irrespective of the presence of steatohepatitis".

R. Stauber, P. Deltenre, C. Lackner, 2020, Journal of hepatology.

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

I. Colle, H. Van Vlierberghe, F. Nevens, 2018, Alimentary pharmacology & therapeutics.

Strategies to manage hepatitis C virus (HCV) disease burden

M. Buti, R. Marinho, T. Berg, 2014, Journal of viral hepatitis.

An inhibitor of interleukin‐6 trans‐signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease

D. Franchimont, O. Moine, J. Devière, 2009, Clinical and experimental immunology.

The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

P. Deltenre, Christophe Moreno, F. Schepis, 2022, Hepatology.

Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study

J. Knebel, P. Deltenre, Christophe Moreno, 2017, PloS one.

Microsatellite polymorphism in the heme oxygenase‐1 gene promoter is not associated with alcoholic liver disease severity

O. Moine, J. Devière, M. Abramowicz, 2014, Hepatology.

A machine learning-based classification of adult-onset diabetes identifies patients at risk of liver-related complications

N. Boon, M. Cnop, J. Devière, 2023, JHEP reports : innovation in hepatology.

Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis

R. Bataller, S. Truant, F. Pruvot, 2015, Gut.

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

T. Hassanein, J. Gervain, M. King, 2014, The New England journal of medicine.

N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

A. Geerts, I. Colle, B. Blomme, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition.

A. Van Gossum, B. Messing, P. Demetter, 2015, JPEN. Journal of parenteral and enteral nutrition.

Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.

P. Deltenre, M. Corouge, S. Dharancy, 2011, Journal of hepatology.

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

F. Glowacki, A. Tran, P. Deltenre, 2011, Alimentary pharmacology & therapeutics.

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.

I. Colle, H. Van Vlierberghe, J. Knebel, 2016, Journal of hepatology.

The protease inhibitor, GS‐9256, and non‐nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

M. Manns, P. Marcellin, H. Mo, 2012, Hepatology.

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

S. Alavian, R. Malekzadeh, V. Wong, 2018, The lancet. Gastroenterology & hepatology.

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Jisoo A. Kwon, R. Malekzadeh, F. Tacke, 2023, The lancet. Gastroenterology & hepatology.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

S. Alavian, M. Manns, Chien-Jen Chen, 2017, The lancet. Gastroenterology & hepatology.

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.

R. Marinho, J. Dufour, P. Thuluvath, 2018, Journal of hepatology.

JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1

M. Buti, M. Biermer, O. Ackaert, 2019, Hepatology.

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen

H. Van Vlierberghe, F. Nevens, S. Ouwerkerk-Mahadevan, 2017, Antimicrobial Agents and Chemotherapy.

Control of acute, chronic, and constitutive hyperammonemia by wild‐type and genetically engineered Lactobacillus plantarum in rodents

J. Devière, P. Goffin, P. Hols, 2008, Hepatology.

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

H. Van Vlierberghe, F. Buntinx, F. Nevens, 2016, Journal of medical virology.

Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation

The concept of MAFLD gathers patients with distinct disease progression trajectories.

P. Deltenre, Christophe Moreno, E. Trépo, 2022, Journal of hepatology.

Early liver transplantation for severe alcoholic hepatitis.

F. Pruvot, D. Samuel, A. Duhamel, 2011, The New England journal of medicine.

A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis

J. Knebel, P. Deltenre, Christophe Moreno, 2023, Hepatology communications.

Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease

J. Devière, T. Gustot, P. Demetter, 2015, European journal of gastroenterology & hepatology.

Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.

D. J. Kim, A. Duhamel, P. Nahon, 2015, Gastroenterology.

Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy.

V. Donckier, T. Gustot, Christophe Moreno, 2014, Journal of hepatology.

REPLY:

T. Gustot, Christophe Moreno, E. Trépo, 2021, Hepatology.

Reply to: "Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis".

T. Gustot, Christophe Moreno, T. Sersté, 2018, Journal of hepatology.

A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2019, Hepatology.

Insulin resistance is associated with esophageal varices in alcoholic liver disease patients

N. Boon, J. Devière, P. Deltenre, 2016, European journal of gastroenterology & hepatology.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation.

I. Colle, H. Van Vlierberghe, N. Boon, 2009, Transplantation proceedings.

Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study.

O. Moine, J. Devière, L. Collignon, 2008, Endoscopy.

Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study

O. Moine, J. Devière, S. Edmundowicz, 2008, Surgical Endoscopy.

The predictive value of FIB‐4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases

G. Verset, Christophe Moreno, N. Nagy, 2008, Hepatology.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

Unusual HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

C. Sarrazin, B. Müllhaupt, P. Buggisch, 2023, Journal of Hepatology.